Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $8.56 USD
Change Today 0.00 / 0.00%
Volume 0.0
NISOF On Other Exchanges
As of 4:30 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

nipro corp (NISOF) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/12/14 - $8.65
52 Week Low
11/28/14 - $8.56
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for NIPRO CORP (NISOF)

Related News

No related news articles were found.

nipro corp (NISOF) Related Businessweek News

View More BusinessWeek News

nipro corp (NISOF) Details

Nipro Corporation, together with its subsidiaries, engages in the medical equipment, pharmaceuticals, and glass businesses in Japan, the United States, Europe, and rest of Asia. The company’s Medical-Related Business segment offers injection and infusion products, artificial organ products, functional products, dialysis products, and diabetic products, as well as renal, intervention and anesthesiology, cardiopulmonary, and pharmaceutical kit products. Its Pharmaceutical-Related Business segment provides injectable drugs, including injection kits, etc.; oral drugs, such as orally-disintegrating tablets, etc.; generic anti-cancer drugs and biosimilars; and drugs for external use. The company’s Glass-Related Business segment offers tube glass for pharmaceuticals, vials, and ampoules; and glass material products for thermos bottles and lighting. Nipro Corporation is also involved in the rental of real estate properties. The company was founded in 1954 and is headquartered in Osaka, Japan.

21,826 Employees
Last Reported Date: 06/26/14
Founded in 1954

nipro corp (NISOF) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nipro corp (NISOF) Key Developments

Nipro Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2014; Provides Dividend Guidance for the Year Ending March 31, 2015; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2015

Nipro Corporation reported consolidated earnings results for the nine months ended December 31, 2014. For the period, the company has reported operating income of ¥13,726 million, ordinary income of ¥18,490 million and net income of ¥14,520 million or ¥85.82 per diluted share on net sales of ¥240,101 million compared to operating income of ¥10,295 million, ordinary income of ¥11,910 million and net income of ¥4,493 million or ¥25.27 per diluted share on net sales of ¥222,619 million reported a year ago. Income before income taxes and minority interests was ¥20,124 million against ¥14,024 million reported last year. For the year ending March 31, 2015, the company expects to pay a dividend of ¥14.50 per share compared to ¥14.50 per share declared last year. The company provided consolidated earnings guidance for the year ending March 31, 2015. For the year, the company expects net sales of ¥330,000 million, operating income of ¥20,000 million, ordinary income of ¥18,600 million and net income of ¥10,400 million or ¥68.97 per share.

Nipro Corporation to Report Q3, 2015 Results on Feb 12, 2015

Nipro Corporation announced that they will report Q3, 2015 results on Feb 12, 2015

Nipro Corporation to Report Q2, 2015 Results on Nov 12, 2014

Nipro Corporation announced that they will report Q2, 2015 results on Nov 12, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NISOF:US $8.56 USD 0.00

NISOF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,310 INR -72.20
Fuso Pharmaceutical Industries Ltd ¥310.00 JPY -1.00
JMS Co Ltd ¥297.00 JPY 0.00
Nikkiso Co Ltd ¥1,102 JPY -19.00
NxStage Medical Inc $18.27 USD -0.06
View Industry Companies

Industry Analysis


Industry Average

Valuation NISOF Industry Range
Price/Earnings 14.9x
Price/Sales 0.5x
Price/Book 1.2x
Price/Cash Flow 15.1x
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NIPRO CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at